Abstract
High saturated fat intake contributes to insulin resistance, β-cell dysfunction, and type 2 diabetes. Developmental programming refers to a stimulus or insult during critical periods of life which includes fetal and subsequent early neonatal life. Programming alters progeny physiology and metabolism with immediate, transient, and durable effects. Maternal nutrition and metabolic state in gestation and lactation shapes progeny development and health. However, paternal nutrition and metabolic state also shapes progeny outcomes, albeit to a lesser extent. A high saturated fat diet ingested by mothers during gestation and/or lactation presents a nutritional insult that induces diabetogenic changes in progeny physiology and metabolism. High-fat programming is induced by maternal high saturated fat intake during defined periods of gestation and/or lactation and programs the physiology and metabolism of the progeny throughout life. This more recently adopted form of developmental programming reflects society in both affluent and developing countries. High-fat programming induces adverse changes in β-cell development and function in neonatal, weanling, and adolescent progeny. These changes are characterized by compromised β-cell development and function, evident by altered expression of key factors that maintain the β-cell phenotype. High-fat programming likely prompts β-cell dysfunction and eventual type 2 diabetes. Dietary consumption, limited in high saturated fat content, particularly in fetal and early postnatal life should be adopted in progeny. Healthy parental nutrition and metabolism pre-, during, and postconception, particularly maternal, should be maintained to enhance progeny health outcomes. These early intervention strategies may prevent the onset of metabolic disease.
Similar content being viewed by others
References
Ackermann AM, Gannon M (2007) Molecular regulation of pancreatic β-cell mass development, maintenance, and expansion. J Mol Endocrinol 38:193–206
Anderson JW, Kendall CW, Jenkins DJ (2003) Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr 22:331–339
Ashcroft FM, Rorsman P (2012) Diabetes mellitus and the beta cell: the last ten years. Cell 148:1160–1171
Bhargava SK, Sachdev HS, Fall CH, Osmond C, Lakshmy R, Barker DJ, Biswas SK, Ramji S, Prabhakaran D, Reddy KS (2004) Relation of serial changes in childhood body mass index to impaired glucose tolerance in young adulthood. N Engl J Med 350:865–875
Brunner Y, Schvartz D, Priego-Capote F, Coute Y, Sanchez JC (2009) Glucotoxicity and pancreatic proteomics. J Proteomics 71:576–591
Cai EP, Casimir M, Schroer SA, Luk CT, Shi SY, Choi D, Dai XQ, Hajmrle C, Spigelman AF, Zhu D, Gaisano HY, MacDonald PE, Woo M (2012) In vivo role of focal adhesion kinase in regulating pancreatic beta-cell mass and function through insulin signaling, actin dynamics, and granule trafficking. Diabetes 61:1708–1718
Cerf ME (2007) High fat diet modulation of glucose sensing in the beta-cell. Med Sci Monit 13:RA12–RA17
Cerf ME (2011) Parental high-fat programming of offspring development, health and beta-cells. Islets 3:118–120
Cerf ME (2012) Developmental programming, hyperglycemia and metabolic outcomes. Nova Science, Hauppauge, pp 73–84
Cerf ME, Louw J (2008) High fat-induced programming of beta-cell development and function in neonatal and weanling offspring. Transworld Research Network, Kerala, pp 133–158
Cerf ME, Louw J (2010) High fat programming induces glucose intolerance in weanling Wistar rats. Horm Metab Res 42:307–310
Cerf ME, Williams K, Nkomo XI, Muller CJ, Du Toit DF, Louw J, Wolfe-Coote SA (2005) Islet cell response in the neonatal rat after exposure to a high-fat diet during pregnancy. Am J Physiol Regul Integr Comp Physiol 288:R1122–R1128
Cerf ME, Muller CJ, Du Toit DF, Louw J, Wolfe-Coote SA (2006) Hyperglycaemia and reduced glucokinase expression in weanling offspring from dams maintained on a high fat diet. Br J Nutr 95:391–396
Cerf ME, Williams K, Chapman CS, Louw J (2007) Compromised beta-cell development and beta-cell dysfunction in weanling offspring from dams maintained on a high-fat diet during gestation. Pancreas 34:347–353
Cerf ME, Chapman CS, Muller CJ, Louw J (2009) Gestational high-fat programming impairs insulin release and reduces Pdx-1 and glucokinase immunoreactivity in neonatal wistar rats. Metabolism 58:1787–1792
Cerf ME, Chapman CS, Louw J (2012) High-fat programming of hyperglycemia, hyperinsulinemia, insulin resistance, hyperleptinemia, and altered islet architecture in 3-month-old wistar rats. ISRN Endocrinol 2012:627270
Chen C, Hosokawa H, Bumbalo LM, Leahy JL (1994) Regulatory effects of glucose on the catalytic activity and cellular content of glucokinase in the pancreatic beta cell. Study using cultured rat islets. J Clin Invest 94:1616–1620
Donath MY, Halban PA (2004) Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47:581–589
Donath MY, Gross DJ, Cerasi E, Kaiser N (1999) Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738–744
Dubois M, Vacher P, Roger B, Huyghe D, Vandewalle B, Kerr-Conte J, Pattou F, Moustaid- Moussa N, Lang J (2007) Glucotoxicity inhibits late steps of insulin exocytosis. Endocrinology 148:1605–1614
Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-Cahn R, Gueripel X, Ellingsgaard H, Schneider MK, Biollaz G, Fontana A, Reinecke M, Homo-Delarche F, Donath MY (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356–2370
Ferreira MR, Lombardo YB, Chicco A (2010) Beta-cell adaptation/dysfunction in an animal model of dyslipidemia and insulin resistance induced by the chronic administration of a sucrose-rich diet. Islets 2:367–373
Giacca A, Xiao C, Oprescu AI, Carpentier AC, Lewis GF (2011) Lipid-induced pancreatic beta-cell dysfunction: focus on in vivo studies. Am J Physiol Endocrinol Metab 300:E255–E262
Gluckman PD, Hanson MA (2004a) The developmental origins of the metabolic syndrome. Trends Endocrinol Metab 15:183–187
Gluckman PD, Hanson MA (2004b) Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr Res 56:311–317
Gniuli D, Calcagno A, Caristo ME, Mancuso A, Macchi V, Mingrone G, Vettor R (2008) Effects of high-fat diet exposure during fetal life on type 2 diabetes development in the progeny. J Lipid Res 49:1936–1945
Godfrey KM, Lillycrop KA, Burdge GC, Gluckman PD, Hanson MA (2007) Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease. Pediatr Res 61:5R–10R
Grasemann C, Devlin MJ, Rzeczkowska PA, Herrmann R, Horsthemke B, Hauffa BP, Grynpas M, Alm C, Bouxsein ML, Palmert MR (2012) Parental diabetes: the Akita mouse as a model of the effects of maternal and paternal hyperglycemia in wildtype offspring. PLoS One 7:e50210
Gregorio BM, Souza-Mello V, Mandarim-de-Lacerda CA, Aguila MB (2013) Maternal high-fat diet is associated with altered pancreatic remodelling in mice offspring. Eur J Nutr 52:759–769
Gremlich S, Bonny C, Waeber G, Thorens B (1997) Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J Biol Chem 272:30261–30269
Heywood WE, Mian N, Milla PJ, Lindley KJ (2004) Programming of defective rat pancreatic beta-cell function in offspring from mothers fed a low-protein diet during gestation and the suckling periods. Clin Sci (Lond) 107:37–45
Jansson N, Nilsfelt A, Gellerstedt M, Wennergren M, Rossander-Hulthen L, Powell TL, Jansson T (2008) Maternal hormones linking maternal body mass index and dietary intake to birth weight. Am J Clin Nutr 87:1743–1749
Jorns A, Tiedge M, Ziv E, Shafrir E, Lenzen S (2002) Gradual loss of pancreatic beta-cell insulin, glucokinase and GLUT2 glucose transporter immunoreactivities during the time course of nutritionally induced type-2 diabetes in Psammomys obesus (sand rat). Virchows Arch 440:63–69
Kasuga M (2006) Insulin resistance and pancreatic beta cell failure. J Clin Invest 116:1756–1760
Khaldi MZ, Guiot Y, Gilon P, Henquin JC, Jonas JC (2004) Increased glucose sensitivity of both triggering and amplifying pathways of insulin secretion in rat islets cultured for 1 wk in high glucose. Am J Physiol Endocrinol Metab 287:E207–E217
Kim JW, Yoon KH (2011) Glucolipotoxicity in pancreatic beta-cells. Diabetes Metab J 35:444–450
Kim Y, Iwashita S, Tamura T, Tokuyama K, Suzuki M (1995) Effect of high-fat diet on the gene expression of pancreatic GLUT2 and glucokinase in rats. Biochem Biophys Res Commun 208:1092–1098
Kiraly MA, Bates HE, Kaniuk NA, Yue JT, Brumell JH, Matthews SG, Riddell MC, Vranic M (2008) Swim training prevents hyperglycemia in ZDF rats: mechanisms involved in the partial maintenance of beta-cell function. Am J Physiol Endocrinol Metab 294:E271–E283
Kulkarni RN, Mizrachi EB, Ocana AG, Stewart AF (2012) Human beta-cell proliferation and intracellular signaling: driving in the dark without a road map. Diabetes 61:2205–2213
LeRoith D (2002) Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities. Am J Med 113:3S–11S
Li D, Yin X, Zmuda EJ, Wolford CC, Dong X, White MF, Hai T (2008) The repression of IRS2 gene by ATF3, a stress-inducible gene, contributes to pancreatic beta-cell apoptosis. Diabetes 57:635–644
Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J (1995) Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 44:1121–1125
Masiello P (2006) Animal models of type 2 diabetes with reduced pancreatic beta-cell mass. Int J Biochem Cell Biol 38:873–893
Muoio DM, Newgard CB (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9:193–205
Navarro-Tableros V, Fiordelisio T, Hernandez-Cruz A, Hiriart M (2007) Physiological development of insulin secretion, calcium channels and GLUT2 expression of pancreatic rat β-cells. Am J Physiol Endocrinol Metab 292:E1018–E1029
Ng SF, Lin RC, Laybutt DR, Barres R, Owens JA, Morris MJ (2010) Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature 467:963–966
Park JH, Stoffers DA, Nicholls RD, Simmons RA (2008) Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest 118:2316–2324
Pick A, Clark J, Kubstrup C, Levisetti M, Pugh W, Bonner-Weir S, Polonsky KS (1998) Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes 47:358–364
Poitout V, Robertson RP (2002) Minireview: secondary beta-cell failure in type 2 diabetes - a convergence of glucotoxicity and lipotoxicity. Endocrinology 143:339–342
Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 29:351–366
Popkin BM (2001) Nutrition in transition: the changing global nutrition challenge. Asia Pac J Clin Nutr 10:S13–S18
Portha B, Chavey A, Movassat J (2011) Early-life origins of type 2 diabetes: fetal programming of the beta-cell mass. Exp Diabetes Res 2011:105076
Prentice AM, Moore SE (2005) Early programming of adult diseases in resource poor countries. Arch Dis Child 90:429–432
Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116:1802–1812
Prentki M, Joly E, El-Assaad W, Roduit R (2002) Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes. Diabetes 51:S405–S413
Reimer MK, Ahren B (2002) Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6 J mice. Diabetes 51:S138–S143
Reusens B, Theys N, Dumortier O, Goosse K, Remacle C (2011) Maternal malnutrition programs the endocrine pancreas in progeny. Am J Clin Nutr 94:1824S–1829S
Rhodes CJ (2005) Type 2 diabetes-a matter of beta-cell life and death? Science 307:380–384
Ruderman N, Prentki M (2004) AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 3:340–351
Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148:852–871
Siebel AL, Mibus A, De Blasio MJ, Westcott KT, Morris MJ, Prior L, Owens JA, Wlodek ME (2008) Improved lactational nutrition and postnatal growth ameliorates impairment of glucose tolerance by uteroplacental insufficiency in male rat offspring. Endocrinology 149:3067–3076
Skelly RH, Bollheimer LC, Wicksteed BL, Corkey BE, Rhodes CJ (1998) A distinct difference in the metabolic stimulus–response coupling pathways for regulating proinsulin biosynthesis and insulin secretion that lies at the level of a requirement for fatty acyl moieties. Biochem J 331:553–561
Sone H, Kagawa Y (2005) Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 48:58–67
Terauchi Y, Sakura H, Yasuda K, Iwamoto K, Takahashi N, Ito K, Kasai H, Suzuki H, Ueda O, Kamada N (1995) Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose. J Biol Chem 270:30253–30256
Terauchi Y, Takamoto I, Kubota N, Matsui J, Suzuki R, Komeda K, Hara A, Toyoda Y, Miwa I, Aizawa S, Tsutsumi S, Tsubamoto Y, Hashimoto S, Eto K, Nakamura A, Noda M, Tobe K, Aburatani H, Nagai R, Kadowaki T (2007) Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest 117:246–257
Utzschneider KM, Carr DB, Hull RL, Kodama K, Shofer JB, Retzlaff BM, Knopp RH, Kahn SE (2004) Impact of intra-abdominal fat and age on insulin sensitivity and beta-cell function. Diabetes 53:2867–2872
Van Raalte DH, Diamant M (2011) Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy? Diabetes Res Clin Pract 93:S37–S46
Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794
Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904
Zambrano E, Bautista CJ, Deas M, Martinez-Samayoa PM, Gonzalez-Zamorano M, Ledesma H, Morales J, Larrea F, Nathanielsz PW (2006) A low maternal protein diet during pregnancy and lactation has sex- and window of exposure-specific effects on offspring growth and food intake, glucose metabolism and serum leptin in the rat. J Physiol 571:221–230
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Cerf, M.E. (2014). High-Fat Programming of β-Cell Dysfunction. In: Islam, M. (eds) Islets of Langerhans, 2. ed.. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6884-0_3-6
Download citation
DOI: https://doi.org/10.1007/978-94-007-6884-0_3-6
Received:
Accepted:
Published:
Publisher Name: Springer, Dordrecht
Online ISBN: 978-94-007-6884-0
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences